Matcha tea: Molecular mechanisms and cardiovascular risk reduction. A literature review.

Authors

Keywords:

Matcha tea, Cardiovascular risk, Molecular mechanism

Abstract

Aim: To establish the relationship between consumption of matcha tea and its benefits in reducing cardiovascular risk by recognizing the different molecular pathways and physiological mechanisms on which this compound and its metabolic agents may intervene, based on an analysis of the published literature. Materials and methods: A search for MeSH terms was carried out through the MeSH database, obtaining search terms such as “green tea”, “Green tea”, “Matcha tea”, “Tea Matcha”, “Matcha tea and cardiovascular risk”, “Matcha tea and cardiovascular risk ”from which a systematic search was carried out in databases such as Medline, Google Academic and Scielo, obtaining articles published between 2007 - 2021, written in Spanish and English and that were original articles and systematic reviews of Literature. Results: The articles reviewed had as a common purpose the study of the bioactive components of matcha green tea and the relationship that exists in terms of the prevention of CVD risk, especially of flavonoids and catechins, supporting the regular consumption of this drink as a potential method for the prevention of cardiovascular diseases, through various mechanisms of action such as antioxidant potential and the impact on the course of atherosclerotic activity, its protective role against injuries caused by ischemia / reperfusion, and the impact of these in reducing inflammation, benefits of these components, conferring a high value in the prevention of CVD to matcha green tea. Conclusions: According to the articles included in this review, it was possible to show that there is a direct relationship between matcha green tea and the reduction of cardiovascular risk, this due to the multiple benefits such as body weight reduction, reduction of cholesterol levels and reduction of injury caused by free radicals that have catechins and flavonoids, the main components of green tea.

Downloads

Download data is not yet available.

Author Biographies

  • Sofía González-Londoño, Pontificia Universidad Javeriana Cali (Colombia)

    Estudiante de Medicina. Semillero de Innovadores en Salud ISSEM.

  • Juan-José Mora-Florez, Pontificia Universidad Javeriana Cali (Colombia)

    Estudiante de Medicina. Semillero de Innovadores en Salud ISSEM.

  • María Isabel Viana-Viana, Pontificia Universidad Javeriana Cali (Colombia)

    Estudiante de Medicina. Semillero de Innovadores en Salud ISSEM.

  • Freddy Moreno-Gómez , Pontificia Universidad Javeriana Cali (Colombia)

    Odontólogo, Magíster en Ciencias Biomédicas, Profesor Departamento de Ciencias Básicas de la Salud.

References

Wolfram S. Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health, Journal of the American College of Nutrition. 2007; 26(4):373S-388S. DOI: 10.1080/07315724.2007.10719626

Boletín observatorio nacional de salud. Enfermedad cardiovascular: principal cau-sa de muerte en Colombia. 2013. p. 1-6. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/Bol etin-tecnico-1-ONS.pdf

Boletín Observatorio Nacional de Salud. Enfermedad cardiovascular: principal causa de muerte en Colombia. 2013. p- 1-6. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/Bol etin-tecnico-1-ONS.pdf

Ceremonia del Té (Japón) Historia y Tradición. Japonpedia Japonpedia. Disponible en: https://japonpedia.com/ceremonia-del-te-en-japon/

Matcha. Kyusuteas.com. Disponible en: https://www.kyusuteas.com/matcha-el-te-verde-mas-saludable

Historia del Té - ¿Cómo Nació el Consumo de Té en Europa y América? Tea Institute. Disponible en: https://www.teainstitute.cl/2020/05/12/historia-del-te-como-nacio-el-consumo-d e-te-en-europa-y-america/

¿Qué son las enfermedades cardiovasculares? Organización Mundial de la Salud. 2021. Disponible en: https://www.who.int/cardiovascular_diseases/about_cvd/es/#:~:text=Definici%C 3%B3n,hipertensi%C3%B3n%20arterial(presi%C3%B3n%20alta)%3B

Jakubczyk K, Kochman J, Kwiatkowska A, Kałduńska J, Dec K, Kawczuga D, Janda K. Antioxidant Properties and Nutritional Composition of Matcha Green Tea. Foods. 2020; 9(4):483. DOI: 10.3390/foods9040483.

Valenzuela BA. El consumo de te y la salud: Características y propiedades benéficas de esta bebida milenaria. Rev Chil Nutr. 2004; 31(2):72-82. DOI: 10.4067/S0717-75182004000200001

Cao SY, Zhao CN, Gan RY, Xu X, Wei XL, Corke H, Atanasov G, et al. Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review. Antioxidants. 2019; 8(6): 166. DOI: 10.3390/antiox8060166

Tránsito-Luengo M. El té verde. Offarm. 2021; 21(05):129-132.

Kochman J, Jakubczyk K, Antoniewicz J, Mruk H, Janda K. Beneficios para la salud y composición quí-mica de Matcha Green Tea: A Review. Moléculas. 2020; 26(1): 85. DOI: 10.3390/molecules26010085

Luis DA, Aller R. Papel de los flavonoides del té en la protección cardiovascular. An Med Interna (Madrid) . 2008; 25(3):105-107.

Hernández-Figueroa TT, Rodríguez-Rodríguez E, Sán-chez-Muniz FJ. El té verde ¿una buena elección para la prevención de enfermedades cardiovasculares? ALAN 2004; 54(4):380-394.

Kim SJ, Li M., Jeong CW et al. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ische-mia–reperfusion injuries through activation of RISK survival pathways in rats. Arch Pharm Res. 2014; 37:1079-1085. DOI: 10.1007/s12272-013-0309-x

Cabrera C, Artacho R, Gimenez R. Beneficial ef-fects of green tea. a review. Journal of the American College of Nutrition . 2006; 25:79-99. DOI: 10.1080/07315724.2006.10719518

Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice Circulation. 2004; 109(20):2448-53. doi: 10.1161/01.CIR.0000128034.70732.C2

Tenorio-López FA, del Valle-Mondragón L, Pastelín-Hernández G. Los flavonoides y el sistema cardiovascular ¿Pueden ser una alternativa terapéutica? Arch Cardiol Méx [revista en Internet]. 2006; 76(Suppl 4):33-45.

Urrútia G, Bonfill X. Declaración PRISMA: Una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 2010; 135(11):507-11. DOI: 10.1016/j.medcli.2010.01.015

Downloads

Published

2022-06-30

Issue

Section

Revisión de la literatura

How to Cite

Matcha tea: Molecular mechanisms and cardiovascular risk reduction. A literature review. (2022). Salutem Scientia Spiritus, 8(2), 58-65. http://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/681

Most read articles by the same author(s)

1 2 3 4 > >>